Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 740947, 10 pages
http://dx.doi.org/10.1155/2014/740947
Research Article

Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments

1Department of Neurology, the First Hospital, Jilin University, Changchun 130021, China
2Department of Neurology, Wuxi People’s Hospital, Nanjing Medical University, Wuxi 214023, China
3Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden
4Department of Otorhinolaryngology, Head and Neck Surgery, the First Hospital, Jilin University, Changchun 130021, China
5Center for Infectious Medicine, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden

Received 18 December 2013; Revised 10 April 2014; Accepted 16 April 2014; Published 12 May 2014

Academic Editor: Fumio Tsuji

Copyright © 2014 Shujuan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shujuan Li, Tao Jin, Hong-Liang Zhang, et al., “Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments,” Mediators of Inflammation, vol. 2014, Article ID 740947, 10 pages, 2014. https://doi.org/10.1155/2014/740947.